…And Amgen Makes Three: Another Ustekinumab Biosimilar Gets Go-Ahead In EU

Third Stelara Rival, Wezenla, Receives Positive Opinion From EMA’s CHMP In April Meeting

 
• By David Wallace
  
Three Numbered Pool Balls With Cue And White Ball
Three Stelara biosimilars have now been cued up in Europe • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products